Skip to main content
. 2022 Aug 5;23(15):8716. doi: 10.3390/ijms23158716

Figure 2.

Figure 2

Distribution of Prosigna® subtypes across (A) Prosigna® risk of recurrence and (B) Prosigna® risk groups. HER2_enr = HER2-enriched; LumA = Luminal A; LumB = Luminal B.